{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:53:00Z","timestamp":1790693580151,"version":"4.1.0"},"reference-count":214,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de Bronconeumolog\u00eda"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.arbres.2022.03.011","type":"journal-article","created":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T16:25:47Z","timestamp":1650039947000},"page":"39-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"S1","title":["Short and Long-Term Impact of COVID-19 Infection on Previous Respiratory Diseases"],"prefix":"10.1016","volume":"58","author":[{"given":"Eusebi","family":"Chiner-Vives","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Cordovilla-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"de la Rosa-Carrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Garc\u00eda-Clemente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Izquierdo-Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remedios","family":"Otero-Candelera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"P\u00e9rez-de Llano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacobo","family":"Sellares-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Ignacio","family":"de Granda-Orive","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arbres.2022.03.011_bib1000","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbres.2022.03.011_bib1005","article-title":"COVID-19 in youth and the fifth wave","author":"Soriano","year":"2021","journal-title":"Arch Bronconeumol (Engl Ed)"},{"key":"10.1016\/j.arbres.2022.03.011_bib1010","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.arbres.2021.02.021","article-title":"Characteristics and risk factors associated with mortality in a multicenter spanish cohort of patients with COVID-19 pneumonia","volume":"57","author":"Mu\u00f1oz-Rodr\u00edguez","year":"2021","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1015","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1186\/s12879-021-06536-3","article-title":"Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients","volume":"21","author":"Dessie","year":"2021","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.arbres.2022.03.011_bib1020","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.arbr.2020.06.010","article-title":"Comorbidities and mortality in patients with COVID-19 aged 60 years and older in a university hospital in Spain","volume":"56","author":"Posso","year":"2020","journal-title":"Arch Bronconeumol (Engl Ed)"},{"key":"10.1016\/j.arbres.2022.03.011_bib1025","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.arbr.2020.05.009","article-title":"Factors associated to hospital admission in a care protocol in COVID-19","volume":"56","author":"Golpe","year":"2020","journal-title":"Arch Bronconeumol (Engl Ed)"},{"key":"10.1016\/j.arbres.2022.03.011_bib1030","first-page":"1","article-title":"Risk and protective factors for COVID-19 morbidity, severity, and mortality","volume":"19","author":"Zhang","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1035","doi-asserted-by":"crossref","first-page":"101505","DOI":"10.1016\/j.genrep.2022.101505","article-title":"Global data analysis and risk factors associated with morbidity and mortality of COVID-19","volume":"26","author":"Tazerji","year":"2022","journal-title":"Gene Rep"},{"key":"10.1016\/j.arbres.2022.03.011_bib1040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12950-020-00250-8","article-title":"SARS-CoV-2 COVID-19 susceptibility and lung inflammatory storm by smoking and vaping","volume":"17","author":"Kaur","year":"2020","journal-title":"J Inflamm (Lond)"},{"key":"10.1016\/j.arbres.2022.03.011_bib1045","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/s41591-020-01227-z","article-title":"Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics","volume":"27","author":"Muus","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.arbres.2022.03.011_bib1050","doi-asserted-by":"crossref","DOI":"10.1016\/j.sjbs.2022.02.006","article-title":"The impact of COVID-19 on the comorbidities: a review of recent updates for combating it","author":"Ahmad Malik","year":"2022","journal-title":"Saudi J Biol Sci"},{"key":"10.1016\/j.arbres.2022.03.011_bib1055","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.arbres.2020.07.025","article-title":"Functional limitations post-COVID-19: a comprehensive assessment strategy","volume":"57","author":"Torres-Castro","year":"2021","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1060","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.arbres.2021.01.036","article-title":"Lung function sequelae in COVID-19 patients 3 months after hospital discharge","volume":"57","author":"Sibila","year":"2021","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1065","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.arbres.2021.04.021","article-title":"Bronchiectasis as a long-term consequence of SARS-COVID-19 pneumonia: future studies are needed","volume":"57","author":"Martinez-Garcia","year":"2021","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1070","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3390\/pathogens11020269","article-title":"Long-term sequelae of COVID-19: a systematic review and meta-analysis of one-year follow-up studies on post-COVID symptoms","volume":"11","author":"Han","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.arbres.2022.03.011_bib1075","first-page":"75","article-title":"Pulmonary function in early follow-up of patients with COVID-19 pneumonia","volume":"57","author":"Tabernero","year":"2021","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1080","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.arbres.2020.08.007","article-title":"Ivermectin treatment may improve the prognosis of patients with COVID-19","volume":"56","author":"Khan","year":"2020","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arbres.2020.06.007","article-title":"Biologic therapy in COVID-19","volume":"57","author":"Gonz\u00e1lez-Gay","year":"2021","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1090","article-title":"Inhaled corticosteroids for the treatment of COVID-19","volume":"3","author":"Griesel","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.arbres.2022.03.011_bib1095","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.arbres.2020.09.017","article-title":"Lung recruitability of COVID-19 pneumonia in patients undergoing helmet CPAP","volume":"57","author":"Amati","year":"2021","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1100","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.arbres.2021.01.012","article-title":"Protective recommendations for non-invasive ventilation during COVID-19 pandemic: a bench evaluation of the effects of instrumental dead space on alveolar ventilation","volume":"57","author":"Delorme","year":"2021","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1105","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.arbres.2021.02.007","article-title":"Non-invasive respiratory support therapies in COVID-19 related acute respiratory failure: looking at the neglected issues","volume":"57","author":"Winck","year":"2021","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1110","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ijid.2021.03.078","article-title":"The use of non-invasive ventilation in COVID-19: a systematic review","volume":"106","author":"Wang","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.arbres.2022.03.011_bib1115","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.arbres.2020.06.002","article-title":"Reinventing the wheel in ARDS: awake proning in COVID-19","volume":"56","author":"Sryma","year":"2020","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1120","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.arbres.2020.06.010","article-title":"COVID-19-related endothelial injury in lung cryobiopsy","volume":"57","author":"Ruiz de Gopegui Miguelena","year":"2021","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1125","unstructured":"Radchenko C. Short- and Long-Term Lung Damage from COVID-19. UC Health. Available from: https:\/\/www.uchealth.com\/en\/media-room\/covid-19\/short-and-long-term-lung-damage-from-covid-19 [accessed 13.3.22]."},{"key":"10.1016\/j.arbres.2022.03.011_bib1130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152749","article-title":"Association between obstructive sleep apnea and community-acquired pneumonia","volume":"11","author":"Chiner","year":"2016","journal-title":"PLOS ONE"},{"key":"10.1016\/j.arbres.2022.03.011_bib1135","article-title":"A systematic review of COVID-19 and obstructive sleep apnoea","volume":"55","author":"Miller","year":"2020","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.arbres.2022.03.011_bib1140","article-title":"Undiagnosed sleep disorder breathing as a risk factor for critical COVID-19 and pulmonary consequences at the midterm follow-up","author":"Labarca","year":"2021","journal-title":"Sleep Med"},{"key":"10.1016\/j.arbres.2022.03.011_bib1145","article-title":"Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study","author":"Cariou","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.arbres.2022.03.011_bib1150","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.202010-3886LE","article-title":"Sleep-disordered breathing among hospitalized patients with COVID-19","volume":"203","author":"Perger","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2022.03.011_bib1155","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.202006-2252LE","article-title":"Sleep apnea and COVID-19 mortality and hospitalization","volume":"202","author":"Cade","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2022.03.011_bib1160","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.sleep.2021.03.029","article-title":"Obstructive sleep apnea (OSA) and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: a systematic review and meta-analysis","volume":"82","author":"Hariyanto","year":"2021","journal-title":"Sleep Med"},{"key":"10.1016\/j.arbres.2022.03.011_bib1165","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S2213-8587(20)30160-1","article-title":"Prevalence of obesity among adult in patients with COVID-19 in France","volume":"8","author":"Caussy","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1170","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.5664\/jcsm.8538","article-title":"Potential influences of obstructive sleep apnea and obesity on COVID-19 severity","volume":"16","author":"McSharry","year":"2020","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.arbres.2022.03.011_bib1175","first-page":"1525","article-title":"Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain","volume":"26","author":"Berenguer","year":"2020","journal-title":"Microbiol Infect"},{"key":"10.1016\/j.arbres.2022.03.011_bib1180","doi-asserted-by":"crossref","DOI":"10.1007\/s11154-014-9304-x","article-title":"Inflammation in sleep apnea: an update","volume":"16","author":"Unnikrishnan","year":"2015","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.arbres.2022.03.011_bib1185","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s11325-019-01967-4","article-title":"Chronic intermittent hypoxia in obstructive sleep apnea: a narrative review from pathophysiological pathways to a precision clinical approach","volume":"24","author":"Labarca","year":"2020","journal-title":"Sleep Breath"},{"key":"10.1016\/j.arbres.2022.03.011_bib1190","doi-asserted-by":"crossref","first-page":"100317","DOI":"10.1016\/j.obmed.2020.100317","article-title":"Hypoxia-inducible factor (HIF): the link between obesity and COVID-19","volume":"22","author":"AbdelMassih","year":"2021","journal-title":"Obes Med"},{"key":"10.1016\/j.arbres.2022.03.011_bib1195","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(20)30216-2","article-title":"COVID-19 cytokine storm: the interplay between inflammation and coagulation","author":"Jose","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.arbres.2022.03.011_bib1200","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.3390\/ijms22062834","article-title":"Coagulation and fibrinolysis in obstructive sleep apnoea","volume":"22","author":"Bikov","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.arbres.2022.03.011_bib1205","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00217.2020","article-title":"COVID-19, ACE2, and the cardiovascular consequences","volume":"318","author":"South","year":"2020","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1210","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1007\/s11695-020-04734-7","article-title":"Obesity and COVID-19: ACE 2, the missing tile","volume":"30","author":"Iannelli","year":"2020","journal-title":"Obes Surg"},{"key":"10.1016\/j.arbres.2022.03.011_bib1215","article-title":"Meta-analysis of effects of obstructive sleep apnea on the renin\u2013angiotensin\u2013aldosterone system","volume":"13","author":"Jin","year":"2016","journal-title":"J Geriatr Cardiol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1220","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s40256-020-00420-2","article-title":"COVID-19 pandemic: cardiovascular complications and future implications","volume":"20","author":"Bandyopadhyay","year":"2020","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.arbres.2022.03.011_bib1225","doi-asserted-by":"crossref","DOI":"10.1016\/j.numecd.2020.05.013","article-title":"Covid-19 and cardiovascular risk: susceptibility to infection to SARS-CoV-2, severity and prognosis of Covid-19 and blockade of the renin\u2013angiotensin\u2013aldosterone system. An evidence-based viewpoint","volume":"30","author":"Cappuccio","year":"2020","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.arbres.2022.03.011_bib1230","unstructured":"World Health Organization. Global Cancer Observatory. International Agency for Research on Cancer 2022. Available from: https:\/\/gco.iarc.fr\/ [accessed 18.3.22]."},{"key":"10.1016\/j.arbres.2022.03.011_bib1235","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.arbres.2020.04.025","article-title":"The beginning of the trend change in lung cancer mortality trends in Spain, 1980\u20132018","volume":"57","author":"Cayuela","year":"2021","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1240","article-title":"Lung cancer screening in patients with chronic obstructive pulmonary disease: do the benefits outweigh the risks?","author":"de-Torres","year":"2021","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1245","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.arbres.2020.03.026","article-title":"Surgical outcomes in a lung cancer-screening program using low dose computed tomography","volume":"57","author":"Mesa-Guzm\u00e1n","year":"2021","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1250","unstructured":"Sociedad Espa\u00f1ola de Oncolog\u00eda M\u00e9dica (SEOM). Las cifras del c\u00e1ncer en Espa\u00f1a 2022. Available from: https:\/\/seom.org\/images\/LAS_CIFRAS_DEL_CANCER_EN_ESPANA_2022.pdf [accessed 18.3.22]."},{"key":"10.1016\/j.arbres.2022.03.011_bib1255","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.arbres.2020.03.023","article-title":"Exploring the impact of lung cancer screening on lung cancer mortality of smokers with obstructive lung disease: analysis of the NLST-ACRIN cohort","volume":"57","author":"de-Torres","year":"2021","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1260","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.arbres.2019.04.019","article-title":"Screening in lung cancer: the latest evidence","volume":"56","author":"Seijo","year":"2020","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1265","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41416-021-01361-6","article-title":"COVID-19 and the multidisciplinary care of patients with lung cancer: an evidence-based review and commentary","volume":"125","author":"Round","year":"2021","journal-title":"Br J Cancer"},{"key":"10.1016\/j.arbres.2022.03.011_bib1270","first-page":"228","article-title":"Lung cancer screening considerations during respiratory infection outbreaks, epidemics or pandemics: an international association for the study of lung cancer early detection and screening committee report","volume":"17","author":"Huber","year":"2022","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"issue":"Suppl. 3","key":"10.1016\/j.arbres.2022.03.011_bib1275","article-title":"ESMO Management and treatment adapted recommendations in the COVID-19 era: lung cancer","volume":"5","author":"Passaro","year":"2020","journal-title":"ESMO Open"},{"key":"10.1016\/j.arbres.2022.03.011_bib1280","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.chest.2020.04.020","article-title":"Management of lung nodules and lung cancer screening during the COVID-19 pandemic: CHEST expert panel report","volume":"158","author":"Mazzone","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2022.03.011_bib1285","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.arbres.2022.03.011_bib1290","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.arbres.2020.05.004","article-title":"Lung cancer patients on the waiting list in the midst of the COVID-19 crisis: what do we do now?","volume":"56","author":"Isea de la Vi\u00f1a","year":"2020","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1295","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.3390\/cancers12082237","article-title":"Cancer management during COVID-19 pandemic: is immune checkpoint inhibitors-based immunotherapy harmful or beneficial?","volume":"12","author":"Vivarelli","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.arbres.2022.03.011_bib1300","doi-asserted-by":"crossref","first-page":"5289","DOI":"10.7150\/jca.49462","article-title":"Expression of the SAR2-Cov-2 receptor ACE2 reveals the susceptibility of COVID-19 in non-small cell lung cancer","volume":"11","author":"Zhang","year":"2020","journal-title":"J Cancer"},{"key":"10.1016\/j.arbres.2022.03.011_bib1305","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.lungcan.2020.05.034","article-title":"Covid-19 and lung cancer: a greater fatality rate?","volume":"146","author":"Rogado","year":"2020","journal-title":"Lung Cancer Amst Neth"},{"key":"10.1016\/j.arbres.2022.03.011_bib1310","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(20)30149-2","article-title":"Risk of COVID-19 for patients with cancer","volume":"21","author":"Wang","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1315","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S1470-2045(20)30314-4","article-title":"COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study","volume":"21","author":"Garassino","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1320","first-page":"9","article-title":"The impact of the COVID-19 pandemic on lung cancer patients","author":"Sha","year":"2020","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.arbres.2022.03.011_bib1325","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1158\/2159-8290.CD-20-0422","article-title":"Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak","volume":"10","author":"Dai","year":"2020","journal-title":"Cancer Discov"},{"key":"10.1016\/j.arbres.2022.03.011_bib1330","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.annonc.2020.06.007","article-title":"COVID-19 in patients with lung cancer","volume":"31","author":"Luo","year":"2020","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1335","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/s43018-020-0104-9","article-title":"SARS-CoV-2 infection in the Italian Veneto region: adverse outcomes in patients with cancer","volume":"1","author":"Rugge","year":"2020","journal-title":"Nat Cancer"},{"key":"10.1016\/j.arbres.2022.03.011_bib1340","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1200\/GO.20.00225","article-title":"Effect of cancer on clinical outcomes of patients with COVID-19: a meta-analysis of patient data","volume":"6","author":"Giannakoulis","year":"2020","journal-title":"JCO Glob Oncol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1345","doi-asserted-by":"crossref","first-page":"e342","DOI":"10.1002\/onco.13604","article-title":"Cancer in lockdown: impact of the COVID-19 pandemic on patients with cancer","volume":"26","author":"Moraliyage","year":"2021","journal-title":"Oncologist"},{"key":"10.1016\/j.arbres.2022.03.011_bib1350","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejca.2020.06.019","article-title":"Impact of the coronavirus disease 2019 pandemic on cancer treatment: the patients\u2019 perspective","volume":"136","author":"de Joode","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.arbres.2022.03.011_bib1355","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ejca.2021.10.009","article-title":"Life-prolonging treatment restrictions and outcomes in patients with cancer and COVID-19: an update from the Dutch Oncology COVID-19 Consortium","volume":"160","author":"de Joode","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.arbres.2022.03.011_bib1360","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1470-2045(20)30388-0","article-title":"The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study","volume":"21","author":"Maringe","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1365","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","article-title":"Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China","volume":"21","author":"Liang","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1370","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.annonc.2020.03.296","article-title":"Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China","volume":"31","author":"Zhang","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1375","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/0284186X.2020.1837946","article-title":"Association of active oncologic treatment and risk of death in cancer patients with COVID-19: a systematic review and meta-analysis of patient data","volume":"60","author":"Park","year":"2021","journal-title":"Acta Oncol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1380","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/j.jtho.2020.04.001","article-title":"Coronavirus disease 2019 or lung cancer: what should we treat?","volume":"15","author":"Russano","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1385","article-title":"How we treat patients with lung cancer during the SARS-CoV-2 pandemic: primum non nocere","volume":"5","author":"Banna","year":"2020","journal-title":"ESMO Open"},{"key":"10.1016\/j.arbres.2022.03.011_bib1390","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1016\/j.jtho.2020.04.012","article-title":"Lessons already learnt from the coronavirus disease 2019 pandemic","volume":"15","author":"Sanz-Santos","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1395","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/j.jtho.2020.05.003","article-title":"The management of patients with lung cancer during the outbreak of coronavirus disease 2019","volume":"15","author":"Ouyang","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1400","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(20)31182-X","article-title":"Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study","volume":"396","author":"COVIDSurg","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.arbres.2022.03.011_bib1405","doi-asserted-by":"crossref","unstructured":"COVIDSurg Collaborative; GlobalSurg Collaborative. Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study. Anaesthesia. 2021;76:748\u201358. doi:10.1111\/anae.15458.","DOI":"10.1111\/anae.15458"},{"key":"10.1016\/j.arbres.2022.03.011_bib1410","article-title":"Dealing with lung cancer in the COVID-19 scenario (a review)","volume":"14","author":"Aran","year":"2021","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1415","doi-asserted-by":"crossref","unstructured":"Thoracic Surgery Outcomes Research Network I, Antonoff M, Backhus L, Boffa DJ, Broderick SR, Brown LM, et al. COVID-19 guidance for triage of operations for thoracic malignancies: A consensus statement from Thoracic Surgery Outcomes Research Network. J Thorac Cardiovasc Surg. 2020;160:601\u20135.","DOI":"10.1016\/j.jtcvs.2020.03.061"},{"key":"10.1016\/j.arbres.2022.03.011_bib1420","doi-asserted-by":"crossref","first-page":"104345","DOI":"10.1016\/j.jcv.2020.104345","article-title":"COVID-19 and telemedicine: immediate action required for maintaining healthcare providers well-being","volume":"126","author":"Moazzami","year":"2020","journal-title":"J Clin Virol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1425","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1089\/jpm.2020.0573","article-title":"\u201cI just need to hold his hand\u201d: telemedicine is powerful","volume":"24","author":"Calton","year":"2021","journal-title":"But Not Perfect J Palliat Med"},{"key":"10.1016\/j.arbres.2022.03.011_bib1430","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.2214\/AJR.20.22976","article-title":"Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: a multicenter study","volume":"214","author":"Zhao","year":"2020","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1435","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.diii.2020.12.002","article-title":"COVID-19: a qualitative chest CT model to identify severe form of the disease","volume":"102","author":"Devie","year":"2021","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.arbres.2022.03.011_bib1440","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1097\/CM9.0000000000001368","article-title":"Bronchiectasis is one of the indicators of severe coronavirus disease 2019 pneumonia","volume":"134","author":"Peng","year":"2021","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.arbres.2022.03.011_bib1445","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1139\/cjpp-2020-0522","article-title":"Clinical study of pulmonary CT lesions and associated bronchiectasis in 115 convalescent patients with novel coronavirus pneumonia (COVID-19) in China","volume":"99","author":"Wang","year":"2021","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1450","doi-asserted-by":"crossref","first-page":"E177","DOI":"10.1148\/radiol.2021203153","article-title":"Six-month follow-up chest CT findings after severe COVID-19 pneumonia","volume":"299","author":"Han","year":"2021","journal-title":"Radiology"},{"key":"10.1016\/j.arbres.2022.03.011_bib1455","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1080\/17476348.2020.1804366","article-title":"Post COVID-19 bronchiectasis: a potential epidemic within a pandemic","volume":"14","author":"Jos\u00e9","year":"2020","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.arbres.2022.03.011_bib1460","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0255659","article-title":"Reduction in hospitalised COPD exacerbations during COVID-19: a systematic review and meta-analysis","volume":"16","author":"Alqahtani","year":"2021","journal-title":"PLOS ONE"},{"key":"10.1016\/j.arbres.2022.03.011_bib1465","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1164\/rccm.202107-1731ED","article-title":"Fewer bronchiectasis exacerbations during the \u201clockdown\u201d for COVID-19: can we convert knowledge into action?","volume":"204","author":"Metersky","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2022.03.011_bib1470","doi-asserted-by":"crossref","DOI":"10.1177\/1753466621995043","article-title":"Impact of bronchiectasis on susceptibility to and severity of COVID-19: a nationwide cohort study","volume":"15","author":"Choi","year":"2021","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.arbres.2022.03.011_bib1475","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1016\/j.jaip.2021.02.041","article-title":"Chronic respiratory diseases and the outcomes of COVID-19: a nationwide retrospective cohort study of 39,420 cases","volume":"9","author":"Guan","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.arbres.2022.03.011_bib1480","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S2213-2600(21)00095-3","article-title":"Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study","volume":"9","author":"Aveyard","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.arbres.2022.03.011_bib1485","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1164\/rccm.202105-1137LE","article-title":"The impact of the COVID-19 pandemic on exacerbations and symptoms in bronchiectasis: a prospective study","volume":"204","author":"Crichton","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2022.03.011_bib1490","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.arbres.2020.04.023","article-title":"Consensus document on the diagnosis and treatment of chronic bronchial infection in chronic obstructive pulmonary disease","volume":"56","author":"de la Rosa Carrillo","year":"2020","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1495","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.arbres.2019.12.021","article-title":"RIBRON: the Spanish online bronchiectasis registry. characterization of the first 1912 patients","volume":"57","author":"Martinez-Garc\u00eda","year":"2021","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1500","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S2213-2600(21)00074-6","article-title":"Living with bronchiectasis during the COVID-19 pandemic","volume":"9","author":"Williamson","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.arbres.2022.03.011_bib1505","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/ACI.0000000000000789","article-title":"COVID-19 in complex common variable immunodeficiency patients affected by lung diseases","volume":"21","author":"Milito","year":"2021","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1510","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04548-2020","article-title":"SARS-CoV-2 infections in people with primary ciliary dyskinesia: neither frequent, nor particularly severe","volume":"58","author":"Pedersen","year":"2021","journal-title":"Eur Respir J"},{"issue":"Suppl. 3","key":"10.1016\/j.arbres.2022.03.011_bib1515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcf.2021.09.002","article-title":"Impact of the COVID-19 pandemic: how our response is shaping the future of cystic fibrosis care","volume":"20","author":"Sabadosa","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.arbres.2022.03.011_bib1520","doi-asserted-by":"crossref","DOI":"10.1513\/AnnalsATS.202105-532OC","article-title":"Changes in care during the COVID-19 pandemic for people with cystic fibrosis","author":"Sanders","year":"2022","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.arbres.2022.03.011_bib1525","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/S2213-2600(20)30177-6","article-title":"Impact of COVID-19 on people with cystic fibrosis","volume":"8","author":"Colombo","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.arbres.2022.03.011_bib1530","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12879-016-1352-2","article-title":"Lessons from a French collaborative case-control study in cystic fibrosis patients during the 2009 A\/H1N1 influenza pandemy","volume":"16","author":"Bucher","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.arbres.2022.03.011_bib1535","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/MCP.0000000000000823","article-title":"COVID-19 outcomes in people with cystic fibrosis","volume":"27","author":"Burgel","year":"2021","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.arbres.2022.03.011_bib1540","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.jcf.2020.10.003","article-title":"The global impact of SARS-CoV-2 in 181 people with cystic fibrosis","volume":"19","author":"McClenaghan","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.arbres.2022.03.011_bib1545","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jcf.2021.03.017","article-title":"Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020","volume":"20","author":"Naehrlich","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.arbres.2022.03.011_bib1550","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.106062","article-title":"Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: incidence and results of the national CF-COVID19-Spain survey","volume":"170","author":"Mondejar-Lopez","year":"2020","journal-title":"Respir Med"},{"key":"10.1016\/j.arbres.2022.03.011_bib1555","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00411-2021","article-title":"Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe","volume":"7","author":"Jung","year":"2021","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.arbres.2022.03.011_bib1560","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/ppul.25250","article-title":"Reduction of pulmonary exacerbations in young children with cystic fibrosis during the COVID-19 pandemic","volume":"56","author":"Patel","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1565","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1038\/d41586-020-02112-y","article-title":"The coronavirus pandemic has forced rapid changes in care protocols for cystic fibrosis","volume":"583","author":"Davies","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.arbres.2022.03.011_bib1570","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jcf.2020.08.013","article-title":"Recommended shielding against COVID-19 impacts physical activity levels in adults with cystic fibrosis","volume":"19","author":"Radtke","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.arbres.2022.03.011_bib1575","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1002\/ppul.25041","article-title":"Physical exercise as a tool to minimize the consequences of the Covid-19 quarantine: an overview for cystic fibrosis","volume":"55","author":"Fernandez-Del-Valle","year":"2020","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1580","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jcf.2020.07.022","article-title":"The impact of the COVID-19 pandemic on the emotional well-being and home treatment of Belgian patients with cystic fibrosis, including transplanted patients and paediatric patients","volume":"19","author":"Havermans","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.arbres.2022.03.011_bib1585","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.7861\/fhj.2020-0205","article-title":"The impact of COVID-19 shielding on the wellbeing, mental health and treatment adherence of adults with cystic fibrosis","volume":"8","author":"Westcott","year":"2021","journal-title":"Future Healthc J"},{"issue":"Suppl. 3","key":"10.1016\/j.arbres.2022.03.011_bib1590","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jcf.2021.08.027","article-title":"Impact of COVID-19 on mental health: effects on screening, care delivery, and people with cystic fibrosis","volume":"20","author":"Smith","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"Suppl. 3","key":"10.1016\/j.arbres.2022.03.011_bib1595","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jcf.2021.08.034","article-title":"Evaluating barriers to and promoters of telehealth during the COVID-19 pandemic at U.S. cystic fibrosis programs","volume":"20","author":"Gifford","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"Suppl. 3","key":"10.1016\/j.arbres.2022.03.011_bib1600","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jcf.2021.09.006","article-title":"Telehealth use in cystic fibrosis during COVID-19: association with race, ethnicity, and socioeconomic factors","volume":"20","author":"Albon","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.arbres.2022.03.011_bib1605","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.jcf.2021.03.009","article-title":"Patient and family perceptions of telehealth as part of the cystic fibrosis care model during COVID-19","volume":"20","author":"Jaclyn","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.arbres.2022.03.011_bib1610","article-title":"The impact of COVID-19 in cystic fibrosis","author":"Flume","year":"2021","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1615","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1002\/ppul.25421","article-title":"Detection of bacterial pathogens using home oropharyngeal swab collection in children with cystic fibrosis","volume":"56","author":"Lenhart-Pendergrass","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1620","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1016\/S0140-6736(20)31040-0","article-title":"Organ procurement and transplantation during the COVID-19 pandemic","volume":"395","author":"Loupy","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.arbres.2022.03.011_bib1625","first-page":"100758","article-title":"Groupe Transplantation Pulmonaire de la Soci\u00e9t\u00e9 de Pneumologie de Langue Fran\u00e7aise SPLF. Impact of the Covid-19 pandemic and lung transplantation program in France","volume":"78","author":"Picard","year":"2020","journal-title":"Respir Med Res"},{"key":"10.1016\/j.arbres.2022.03.011_bib1630","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1164\/rccm.202011-4153OC","article-title":"Rapid improvement after starting elexacaftor\u2013tezacaftor\u2013ivacaftor in patients with cystic fibrosis and advanced pulmonary disease","volume":"204","author":"Burgel","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2022.03.011_bib1635","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jcf.2020.12.007","article-title":"The impact of SARS-CoV-2 on the cystic fibrosis foundation therapeutics development network","volume":"20","author":"Pearson","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.arbres.2022.03.011_bib1640","doi-asserted-by":"crossref","first-page":"708","DOI":"10.3390\/vaccines9070708","article-title":"Serological response in lung transplant recipients after two doses of SARS-CoV-2 mRNA vaccines","volume":"9","author":"Narasimhan","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.arbres.2022.03.011_bib1645","article-title":"Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis","volume":"14","author":"Guan","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2022.03.011_bib1650","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0233147","article-title":"Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis","volume":"15","author":"Alqahtani","year":"2020","journal-title":"PLOS ONE"},{"key":"10.1016\/j.arbres.2022.03.011_bib1655","doi-asserted-by":"crossref","first-page":"105941","DOI":"10.1016\/j.rmed.2020.105941","article-title":"Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19)","volume":"167","author":"Lippi","year":"2020","journal-title":"Respir Med"},{"key":"10.1016\/j.arbres.2022.03.011_bib1660","doi-asserted-by":"crossref","first-page":"E3259","DOI":"10.3390\/jcm9103259","article-title":"Characteristics and prognosis of COVID-19 in patients with COPD","volume":"9","author":"Graziani","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.arbres.2022.03.011_bib1665","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.arbres.2021.01.001","article-title":"COPD and COVID-19","volume":"57","author":"Halpin","year":"2021","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1670","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.arbres.2020.05.007","article-title":"Asthma and COPD in hospitalized COVID-19 patients","volume":"56","author":"Garc\u00eda-Pach\u00f3n","year":"2020","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1675","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.arbres.2021.02.006","article-title":"Impact of COVID-19 on the most frequent middle and lower obstructive airway diseases\/syndromes in adult population","volume":"57","author":"Tiotiu","year":"2021","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1680","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S2213-2600(20)30415-X","article-title":"Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform","volume":"8","author":"Schultze","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.arbres.2022.03.011_bib1685","first-page":"136","article-title":"Nebulized treatments and the possible risk of coronavirus transmission: where is the evidence?","volume":"7","author":"Tashkin","year":"2020","journal-title":"Chronic Obstr Pulm Dis"},{"key":"10.1016\/j.arbres.2022.03.011_bib1690","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/jebm.12381","article-title":"Effectiveness of N95 respirators versus surgical masks against influenza: a systematic review and meta-analysis","volume":"13","author":"Long","year":"2020","journal-title":"J Evid Based Med"},{"key":"10.1016\/j.arbres.2022.03.011_bib1695","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M20-2003","article-title":"Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study","volume":"173","author":"Wichmann","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.arbres.2022.03.011_bib1700","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.arbres.2022.03.011_bib1705","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","article-title":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study","volume":"46","author":"Helms","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.arbres.2022.03.011_bib1710","doi-asserted-by":"crossref","first-page":"100639","DOI":"10.1016\/j.eclinm.2020.100639","article-title":"Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: a systematic review and meta-analysis","volume":"29","author":"Malas","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.arbres.2022.03.011_bib1715","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijid.2020.08.023","article-title":"A meta-analysis of the incidence of venous thromboembolic events and impact of anticoagulation on mortality in patients with COVID-19","volume":"100","author":"Lu","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.arbres.2022.03.011_bib1720","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.arbres.2020.07.033","article-title":"Thrombotic risk and Covid-19: review of current evidence for a better diagnostic and therapeutic approach","volume":"57","author":"L\u00f3pez-Reyes","year":"2021","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1725","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.arbres.2020.06.013","article-title":"Pulmonary embolism in patients with Covid-19 pneumonia: the utility of D-dimer","volume":"56","author":"Rodriguez-Sevilla","year":"2020","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1730","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.medcli.2021.03.028","article-title":"Predicci\u00f3n del desarrollo de tromboembolia pulmonar en pacientes con infecci\u00f3n por SARS-CoV-2","volume":"158","author":"Mosquera","year":"2021","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.arbres.2022.03.011_bib1735","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1016\/j.jacc.2020.04.031","article-title":"COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review","volume":"75","author":"Bikdeli","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1740","article-title":"Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials","author":"Ortega-Paz","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.arbres.2022.03.011_bib1745","unstructured":"The National Institute for Health and Care Excellence (NICE) \u2013 NICECOVID-19 rapid guideline: Managing COVID19 v22.0-10\/3\/22 [Internet]. Available from: https:\/\/app.magicapp.org\/#\/guideline\/6143\/section\/98163 [accessed 19.3.22]."},{"key":"10.1016\/j.arbres.2022.03.011_bib1750","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.thromres.2021.03.006","article-title":"Incidence and mortality due to thromboembolic events during the COVID-19 pandemic: multi-sourced population-based health records cohort study","volume":"202","author":"Aktaa","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.arbres.2022.03.011_bib1755","first-page":"34","article-title":"Assessment of pulmonary arterial circulation 3 months after hospitalization for SARS-CoV-2 pneumonia: dual-energy CT (DECT) angiographic study in 55 patients","author":"Remy-Jardin","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.arbres.2022.03.011_bib1760","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S2213-2600(21)00286-1","article-title":"The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease","volume":"9","author":"Adeloye","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.arbres.2022.03.011_bib1765","first-page":"1068","article-title":"Cardiovascular implications of the COVID-19 pandemic: a global perspective","volume":"36","author":"Boukhris","year":"2020","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1770","doi-asserted-by":"crossref","unstructured":"Bartczak K, Milkowska-dymanowska J. The Utility of Telemedicine In Managing Patients After COVID 19. Res Square. 2022;1-11. Available from: https:\/\/www.researchsquare.com\/article\/rs1293204\/v1?utm_source=researcher_app&utm_medium=referral&utm_campaign=RESR_MRKT_Researcher_inbound [accessed 19.3.22].","DOI":"10.21203\/rs.3.rs-1293204\/v1"},{"key":"10.1016\/j.arbres.2022.03.011_bib1775","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.796094","article-title":"Asthma associated cytokines regulate the expression of SARSCoV-2 receptor ACE2 in the lung tissue of asthmatic patients","volume":"12","author":"Saheb Sharif-Askari","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1780","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.arbres.2022.03.011_bib1785","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S2213-2600(21)00013-8","article-title":"Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK","volume":"9","author":"Bloom","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.arbres.2022.03.011_bib1790","doi-asserted-by":"crossref","first-page":"21805","DOI":"10.1038\/s41598-020-77791-8","article-title":"Impact of comorbid asthma on severity of coronavirus disease (COVID-19)","volume":"10","author":"Lee","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.arbres.2022.03.011_bib1795","article-title":"Asthma phenotypes and COVID-19 risk: a population-based observational study","author":"Bloom","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2022.03.011_bib1800","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jaip.2020.11.054","article-title":"Prevalence of comorbid asthma and related outcomes in COVID-19: a systematic review and metaanalysis","volume":"9","author":"Liu","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.arbres.2022.03.011_bib1805","doi-asserted-by":"crossref","first-page":"210152","DOI":"10.1183\/16000617.0152-2021","article-title":"Asthma and COVID-19: an update","volume":"30","author":"Adir","year":"2021","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.arbres.2022.03.011_bib1810","article-title":"Risk of serious COVID-19 outcomes among adults with asthma in Scotland: a national incident cohort study","author":"Shi","year":"2022","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.arbres.2022.03.011_bib1815","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2021.12.044","article-title":"Prevalence and risk associated with asthma in children hospitalized with SARS-CoV-2: a meta-analysis and systematic review","author":"Mongkonsritragoon","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.arbres.2022.03.011_bib1820","doi-asserted-by":"crossref","DOI":"10.1016\/j.anai.2022.01.027","article-title":"The effect of coronavirus disease 2019 on asthma visits","author":"Stout","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1825","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1164\/rccm.202003-0821OC","article-title":"COVID-19 related genes in sputum cells in asthma: relationship to demographic features and corticosteroids","volume":"202","author":"Peters","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2022.03.011_bib1830","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.resinv.2019.12.005","article-title":"Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells","volume":"58","author":"Yamaya","year":"2020","journal-title":"Respir Investig"},{"key":"10.1016\/j.arbres.2022.03.011_bib1835","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1165\/rcmb.2010-0169OC","article-title":"Acute lung injury induces cardiovascular dysfunction: effects of IL-6 and budesonide\/formoterol","volume":"45","author":"Suda","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1840","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S2213-2600(21)00160-0","article-title":"Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial","volume":"9","author":"Ramakrishnan","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.arbres.2022.03.011_bib1845","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0140-6736(21)01744-X","article-title":"Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial","volume":"398","author":"Yu","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.arbres.2022.03.011_bib1850","article-title":"Inhaled and intranasal ciclesonide for the treatment of covid-19 in adult outpatients: CONTAIN phase II randomised controlled trial","volume":"375","author":"Ezer","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.arbres.2022.03.011_bib1855","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/jamainternmed.2021.6759","article-title":"Efficacy of inhaled ciclesonide for outpatient treatment of adolescents and adults with symptomatic COVID-19: a randomized clinical trial","volume":"182","author":"Clemency","year":"2022","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.arbres.2022.03.011_bib1860","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03036-2021","article-title":"Add-on inhaled budesonide in the treatment of hospitalised patients with COVID-19: a randomised clinical trial","author":"Agust\u00ed","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2022.03.011_bib1865","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02921-2021","article-title":"Inhaled corticosteroids for outpatients with Covid-19: a meta-analysis","author":"Lee","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2022.03.011_bib1870","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/ni.1981","article-title":"Eosinophils are required for the maintenance of plasma cells in the bone marrow","volume":"12","author":"Chu","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1875","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.202111-2496LE","article-title":"Reduced COVID-19 vaccine response in patients treated with biologic therapies for asthma","author":"Runnstrom","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2022.03.011_bib1880","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1164\/rccm.201701-0120OC","article-title":"Effects of omalizumab on rhinovirus infections, illnesses, and exacerbations of asthma","volume":"196","author":"Esquivel","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2022.03.011_bib1885","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03142-2020","article-title":"The impact of COVID-19 on patients with asthma","volume":"57","author":"Izquierdo","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2022.03.011_bib1890","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jaip.2020.09.050","article-title":"Clinical characteristics in 545 patients with severe asthma on biological treatment during the COVID-19 outbreak","volume":"9","author":"Rial","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.arbres.2022.03.011_bib1895","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/all.14516","article-title":"COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: results from a multicenter Italian survey","volume":"76","author":"Matucci","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.arbres.2022.03.011_bib1900","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-021-01647-6","article-title":"Preexisting respiratory diseases and clinical outcomes in COVID-19: a multihospital cohort study on predominantly African American population","volume":"22","author":"Lohia","year":"2021","journal-title":"Respir Res"},{"key":"10.1016\/j.arbres.2022.03.011_bib1905","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.arbres.2020.11.012","article-title":"Prevalence and 30-day mortality in hospitalized patients with covid-19 and prior lung diseases","volume":"57","author":"Signes-Costa","year":"2021","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1910","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1164\/rccm.202006-2441LE","article-title":"Increased odds of death for patients with interstitial lung disease and COVID-19: a case\u2013control study","volume":"202","author":"Esposito","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2022.03.011_bib1915","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04125-2020","article-title":"Interstitial lung disease increases susceptibility to and severity of COVID-19","volume":"58","author":"Lee","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2022.03.011_bib1920","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1164\/rccm.202007-2638LE","article-title":"Risk factors for mortality after COVID-19 in patients with preexisting interstitial lung disease","volume":"203","author":"Gallay","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2022.03.011_bib1925","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1164\/rccm.202007-2794OC","article-title":"Outcome of hospitalization for COVID-19 in patients with interstitial lung disease an international multicenter study","volume":"202","author":"Drake","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2022.03.011_bib1930","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.3390\/jcm10112452","article-title":"Post-COVID-19 pulmonary fibrosis: novel sequelae of the current pandemic","volume":"10","author":"Ambardar","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.arbres.2022.03.011_bib1935","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.trsl.2021.09.001","article-title":"From ARDS to pulmonary fibrosis: the next phase of the COVID-19 pandemic?","volume":"241","author":"Michalski","year":"2022","journal-title":"Transl Res"},{"key":"10.1016\/j.arbres.2022.03.011_bib1940","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmed.2022.815924","article-title":"COVID-19-triggered acute exacerbation of IPF, an underdiagnosed clinical entity with two-peaked respiratory failure: a case report and literature review","volume":"9","author":"Goto","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.arbres.2022.03.011_bib1945","first-page":"1","article-title":"Personal View Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy","volume":"2600","author":"George","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.arbres.2022.03.011_bib1950","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02806-2021","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis after SARS-CoV-2 vaccination","volume":"59","author":"Bando","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2022.03.011_bib1955","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijid.2022.01.031","article-title":"Case report: Acute exacerbation of interstitial pneumonia related to messenger RNA COVID-19 vaccination","volume":"116","author":"Amiya","year":"2022","journal-title":"Int J Infec Dis"},{"key":"10.1016\/j.arbres.2022.03.011_bib1960","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.chest.2021.07.2160","article-title":"An acute exacerbation of idiopathic pulmonary fibrosis after BNT162b2 mRNA COVID-19 vaccination: a case report","volume":"161","author":"Ghincea","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2022.03.011_bib1965","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.chest.2020.04.019","article-title":"Practical considerations for the diagnosis and treatment of fibrotic interstitial lung disease during the coronavirus disease 2019 pandemic","volume":"158","author":"Wong","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2022.03.011_bib1970","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1513\/AnnalsATS.202103-319RL","article-title":"Home oxygen monitoring in patients with interstitial lung disease","volume":"19","author":"Carde\u00f1osa","year":"2022","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.arbres.2022.03.011_bib1975","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1164\/rccm.202002-0328OC","article-title":"Home monitoring in patients with idiopathic pulmonary fibrosis: a randomized controlled trial","volume":"202","author":"Moor","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2022.03.011_bib1980","doi-asserted-by":"crossref","DOI":"10.1177\/2040622320935765","article-title":"Current smoking, former smoking, and adverse outcome among hospitalized COVID-19 patients: a systematic review and meta-analysis","volume":"11","author":"Farsalinos","year":"2020","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.arbres.2022.03.011_bib1985","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s11739-020-02473-2","article-title":"Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?","volume":"15","author":"Takagi","year":"2020","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.arbres.2022.03.011_bib1990","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.arbres.2020.06.024","article-title":"COVID-19 and smoking: a systematic review and meta-analysis of the evidence","volume":"57","author":"Jim\u00e9nez-Ruiz","year":"2021","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2022.03.011_bib1995","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.arbres.2021.01.005","article-title":"Reply to \u201csmoker, former smoker and COVID-19\u201d","volume":"57","author":"Jim\u00e9nez-Ruiz","year":"2021","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2022.03.011_bib2000","doi-asserted-by":"crossref","first-page":"101313","DOI":"10.1016\/j.eujim.2021.101313","article-title":"Association of smoking history with severe and critical outcomes in COVID-19 patients: a systemic review and meta-analysis","volume":"43","author":"Zhang","year":"2021","journal-title":"Eur J Integr Med"},{"key":"10.1016\/j.arbres.2022.03.011_bib2005","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1186\/s12889-021-11579-x","article-title":"Smoking is associated with worse outcomes of COVID-19 particularly among younger adults: a systematic review and meta-analysis","volume":"21","author":"Patanavanich","year":"2021","journal-title":"BMC Public Health"},{"key":"10.1016\/j.arbres.2022.03.011_bib2010","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1136\/thoraxjnl-2020-216422","article-title":"Current smoking and COVID-19 risk: results from a population symptom app in over 2.4 million people","volume":"76","author":"Hopkinson","year":"2021","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2022.03.011_bib2015","doi-asserted-by":"crossref","DOI":"10.1177\/21501319211062672","article-title":"Symptoms COVID 19 positive vapers compared to COVID 19 positive non-vapers","volume":"13","author":"McFadden","year":"2022","journal-title":"J Prim Care Community Health"},{"key":"10.1016\/j.arbres.2022.03.011_bib2020","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3390\/ijerph19020630","article-title":"Changes in cigarette smoking and vaping in response to the COVID-19 pandemic in the UK: findings from baseline and 12-month follow up of HEBECO study","volume":"19","author":"Kale","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.arbres.2022.03.011_bib2025","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.arbres.2021.03.011","article-title":"COVID-19 and smoking: an opportunity to quit","volume":"57","author":"Pastor Espl\u00e1","year":"2021","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2022.03.011_bib2030","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/ntr\/ntaa207","article-title":"The impact of COVID-19 on smoking patterns in pakistan: findings from a longitudinal survey of smokers","volume":"23","author":"Siddiqi","year":"2021","journal-title":"Nicotine Tob Res"},{"key":"10.1016\/j.arbres.2022.03.011_bib2035","doi-asserted-by":"crossref","DOI":"10.1177\/1179173X211053022","article-title":"Beliefs toward smoking and COVID-19, and the pandemic impact on smoking behavior and quit intention: findings from a community-based cross-sectional study in Jordan","volume":"14","author":"Al-Tammemi","year":"2021","journal-title":"Tob Use Insights"},{"key":"10.1016\/j.arbres.2022.03.011_bib2040","doi-asserted-by":"crossref","first-page":"106917","DOI":"10.1016\/j.addbeh.2021.106917","article-title":"How the COVID-19 pandemic impacts tobacco addiction: changes in smoking behavior and associations with well-being","volume":"119","author":"Yang","year":"2021","journal-title":"Addict Behav"},{"key":"10.1016\/j.arbres.2022.03.011_bib2045","doi-asserted-by":"crossref","first-page":"53","DOI":"10.18332\/tpc\/127122","article-title":"How has the COVID-19 pandemic affected tobacco users in India: lessons from an ongoing tobacco cessation program","volume":"6","author":"Gupte","year":"2020","journal-title":"Tob Prev Cessat"},{"key":"10.1016\/j.arbres.2022.03.011_bib2050","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.arbres.2021.07.004","article-title":"Tobacco, tobacco control and Covid-19: understanding their associations","volume":"58","author":"Clancy","year":"2022","journal-title":"Arch Bronconeumol"},{"issue":"Pt B","key":"10.1016\/j.arbres.2022.03.011_bib2055","article-title":"Impacts of COVID-19 on cigarette use, smoking behaviors, and tobacco purchasing behaviors","volume":"229","author":"Maloney","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.arbres.2022.03.011_bib2060","first-page":"2","article-title":"COVID-19 Impact on smokers participating in smoking cessation trials: the experience of nondaily smokers participating in a smartphone app study","author":"Hoeppner","year":"2020","journal-title":"Telemed Rep"},{"key":"10.1016\/j.arbres.2022.03.011_bib2065","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.arbres.2020.07.014","article-title":"COVID-19 and tobacco","volume":"57","author":"R\u00e1bade Castedo","year":"2021","journal-title":"Arch Bronconeumol"}],"container-title":["Archivos de Bronconeumolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289622002915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289622002915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:42:09Z","timestamp":1759531329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300289622002915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":214,"alternative-id":["S0300289622002915"],"URL":"https:\/\/doi.org\/10.1016\/j.arbres.2022.03.011","relation":{},"ISSN":["0300-2896"],"issn-type":[{"value":"0300-2896","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Short and Long-Term Impact of COVID-19 Infection on Previous Respiratory Diseases","name":"articletitle","label":"Article Title"},{"value":"Archivos de Bronconeumolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arbres.2022.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 SEPAR. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}